Laser devices for vaginal rejuvenation: effectiveness, regulation and marketing

20.500.12592/r0fvp0

Laser devices for vaginal rejuvenation: effectiveness, regulation and marketing

26 Jan 2023

The North American Menopause Society guideline makes a strong recommendation for over-the-counter products as the first-line treat- ment of GSM, and for vaginal estrogen as the second-line treatment For GSM, a systematic review published in 2021 identified 26 studies for patients with moderate-to-severe GSM.1 In randomized con- with 2678 participants who had GSM and were treated with a vagin al tr. [...] Women harmed by vaginal laser for patients who pay for these procedures cannot be tracked, nor can treatment of GSM: the latest casualties of fear and confusion surrounding hor- the exact number of vaginal laser systems that are active in Canada. [...] The efficacy of vaginal laser and other online, and the diverse benefits of vaginal rejuvenation are listed on energy-based treatments on genital symptoms in post-menopausal women: a sys-tematic review and meta-analysis. [...] The use of vaginal lasers in the treatment of urinary incontin- of urinary incontinence and GSM, as well as for less clear indications ence and overactive bladder, systematic review. [...] However, it is not Becton, Dickinson and Company, outside of this work, and is the clear if or how advertising by medical providers is actively moni- vice president of the International Neuro-Urology Society and of the tored by regulatory authorities.
Pages
2
Published in
Canada